From: Prognostic impact of lymph node and surgical margin in patients with perihilar cholangiocarcinoma
Characteristic | Total(n = 71) |
---|---|
Age (mean ± SD), years | 62.5 ± 9.7 |
Gender, n (%) | |
Male | 50 (70.4%) |
Female | 21 (29.6%) |
PBD, n (%) | 63 (88.7%) |
ENBD | 61 (85.9%) |
PTCD | 2(2.8%) |
Intraoperative blood loss (median, IQR), ml | 1000.0 (600.0–1400.0) |
Intraoperative blood transfusion (median, IQR), ml | 1000.0 (400.0–1300.0) |
Operative time (median, IQR), min | 570.0 (495.0–670.0) |
Type of liver resection, n (%) | |
S1,4,5,6,7,8 | 7 (9.9%) |
S1,5,6,7,8 | 23 (32.4%) |
S1,2,3,4,5,8 | 6 (8.5%) |
S1,2,3,4 | 31 (43.7%) |
S1,4b,5/S4b,5/S1 | 2 (2.8%) |
Without hepatectomy | 2 (2.8%) |
Combined resection, n (%) | |
Pancreaticoduodenectomy | 7 (9.9%) |
Portal vein resection | 17 (23.9%) |
Hepatic artery resection | 6 (8.5%) |
Bismuth classification, n (%) | |
I/II | 9 (12.7%) |
III | 41 (57.7%) |
IV | 21 (29.6%)) |
Differentiation grade, n (%) | |
Poor | 21 (29.6%) |
Moderate/Well | 50 (70.4%) |
Microscopic perineural invasion, n (%) | 59 (83.1%) |
Microvascular invasion, n (%) | 12 (16.9%) |
Macrovascular invasion, n (%) | 44 (61.9%) |
Tumor classification, n (%) | |
0 | 1 (1.4%) |
1 | 7 (9.9%) |
2a/b | 19 (26.8%) |
3 | 27 (38.0%) |
4 | 17 (23.9%) |
Node classification, n (%) | |
0 | 39 (54.9%) |
1/2 | 32 (45.1%) |
Stage, n (%) | |
0 | 1 (1.4%) |
I | 6 (8.5%) |
II | 12 (16.9%) |
IIIA/IIIB | 44 (61.9%) |
IVA | 4 (5.6%) |
IVB | 4 (5.6%) |
Resection margin, n (%) | |
R0 | 57 (80.3%) |
R1/2 | 14 (19.7%) |
Postoperative complication, n (%) | |
PHLF | 5 (7.0%) |
BL | 24 (33.8%) |
Major postoperative complication | 17 (23.9%) |
Organ/space SSI | 38 (53.5%) |
Incisional SSI | 7 (9.9%) |
Abdominal hemorrhage | 3 (4.2%) |
DGE | 7 (9.9%) |
CR-POPF | 5 (7.0%) |
CL | 10 (14.1%) |
Relaparotomy | 5 (7.0%) |
Hospital stay (median, IQR), day | 21.0 (18.0–31.0) |
Postoperative adjuvant chemotherapy, n (%) | 58 (81.7%) |